LON:EVG Evgen Pharma (EVG) Share Price, News & Analysis GBX 0.80 0.00 (0.00%) (As of 04/25/2024) Add Compare Share Share Today's Range 0.80▼ 0.8050-Day Range 0.80▼ 0.8052-Week Range 0.70▼ 4.05Volume227,410 shsAverage Volume1.73 million shsMarket Capitalization£3.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Evgen Pharma alerts: Email Address Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About Evgen Pharma Stock (LON:EVG)Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.Read More EVG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVG Stock News HeadlinesApril 4, 2024 | lse.co.ukTRADING UPDATES: Northcoders launches bootcamp; Schroder investsMarch 20, 2024 | marketwatch.comEvgen to Raise Up to $2.4 Mln; to Change Name After Acquiring Chronos TherapeuticsJuly 26, 2024 | Porter & Company (Ad)We recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…February 27, 2024 | lse.co.ukEvgen Pharma finds evidence of SFX-01 activity in colon cancer modelsFebruary 14, 2024 | msn.comPharma middlemen face govt. scrutiny over generic drug shortagesJanuary 26, 2024 | lse.co.ukEvgen Pharma Share ChatDecember 4, 2023 | finance.yahoo.comMetastatic HR+/HER2− Breast Cancer Market is Expected to Showcase a Significant Growth at a CAGR of 9.3% by 2032, Predicts DelveInsightOctober 31, 2023 | finance.yahoo.comEvgen Pharma "delighted" with cash position after promising first halfJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.September 5, 2023 | lse.co.ukEvgen Pharma hires interim CFO from Faron, chair to retire this monthSeptember 5, 2023 | marketwatch.comEvgen Pharma Chair Barry Clare Steps Down; Appoints New Interim Chair, Interim CFOAugust 15, 2023 | marketwatch.comEvgen Pharma Shares Rise on Positive SFX-01 Tablet ReportAugust 2, 2023 | marketwatch.comEvgen Pharma Shares Fall on Ending of License DealJune 19, 2023 | lse.co.ukEvgen collaborator receives grant from KWF Dutch Cancer SocietyJune 7, 2023 | lse.co.ukEvgen Pharma confident amid Stalicla deal; CFO Moulson to retireMarch 22, 2023 | marketwatch.comEvgen Pharma Results From SFX-01 Tablet Trial Meet ExpectationsMarch 16, 2023 | marketwatch.comEvgen Pharma Shares Rise on Drug Candidate DataMarch 13, 2023 | msn.comTHG and musicMagpie move to reassure investors as Silicon Valley Bank's UK arm is sold to HSBCSee More Headlines Receive EVG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evgen Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/15/2020Today7/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryFinancial Services Current SymbolLON:EVG CUSIPN/A CIKN/A Webevgen.com Phone+44-151-7053532FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-3,350,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-60.57% Return on Assets-45.52% Debt Debt-to-Equity RatioN/A Current Ratio10.39 Quick Ratio23.15 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.47 per share Price / Cash Flow1.71 Book ValueGBX 1 per share Price / Book0.80Miscellaneous Outstanding Shares427,350,000Free FloatN/AMarket Cap£3.42 million OptionableNot Optionable Beta1.44 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Huw Jones BSc (Age 65)Ph.D., CEO & Executive Director Comp: $304.73kMr. Toni Haenninen (Age 47)CFO & Director Dr. Helen KuhlmanChief Business OfficerDr. Glen Clack FFPMM.D., Chief Medical OfficerKey CompetitorsGlenveagh PropertiesLON:GLVPCF GroupLON:PCF3676421 (PFL.L)LON:PFL521142 (CHW.L)LON:CHWEF RealisationLON:EFRView All CompetitorsInsidersToni HänninenBought 1,000,000 shares on 4/5/2024Total: £1 M ($1.00/share) EVG Stock Analysis - Frequently Asked Questions How have EVG shares performed this year? Evgen Pharma's stock was trading at GBX 1.60 at the beginning of 2024. Since then, EVG stock has decreased by 50.0% and is now trading at GBX 0.80. View the best growth stocks for 2024 here. How were Evgen Pharma's earnings last quarter? Evgen Pharma plc (LON:EVG) released its quarterly earnings data on Monday, June, 15th. The company reported ($2.10) earnings per share for the quarter, hitting the consensus estimate of ($2.10). How do I buy shares of Evgen Pharma? Shares of EVG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Evgen Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evgen Pharma investors own include MOTIF BIO PLC/S (MTFB), Capital & Counties Properties PLC (CAPC), Obtala (OBT), Tertiary Minerals (TYM), Veltyco Group (VLTY), Atalaya Mining (AYM) and AllianceBernstein Global High Income Fund (AWF). This page (LON:EVG) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evgen Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Evgen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.